From July 1, 2022 to September 30, 2022, the company has repurchased 1,631,700 shares, representing 0.14% for CNY 32.03 million. With this, the company has completed the repurchase of 9,199,916 shares, representing 0.79% for CNY 200.16 million under the buyback announced on May 5, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.54 CNY | -0.34% | -2.74% | -5.52% |
17/04 | Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
10/04 | Apeloa Pharmaceutical Co.,Ltd Approves Cash Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.52% | 2.35B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 000739 Stock
- News Apeloa Pharmaceutical Co.,Ltd
- Tranche Update on Apeloa Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on May 5, 2022.